Artios
ID: 5849921Artios Pharma develops cancer treatments that target DNA damage response (DDR) pathways to kill cancer cells selectively
5
Funding Rounds
$535.2m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Artios has raised a total of $451.2m in funding over 5 rounds.
Key Insights:
- Artios Series D Round, November 2025: $115m
- Artios Pharma Series C round, July 27, 2021: $153m
- Artios Pharma July 2021 Series C Funding Round: $150m
- Artios Pharma Series A round, September 2016: $33.2m
- Artios Pharma Limited funding round, August 2018: $84m
Industries
Artios is active in the following industries: